Publications

In Vitro Activity of Nine Developmental Cationic Steroid Compounds (Ceragenins) Against Clinical Isolates of Clostridium difficile, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of DX-619 Compared to Other Agents against Viridans Streptococci, Lead author: Smith K, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Pneumococcal Conjugate Vaccine Effect on S. pneumoniae Serotype Carriage and Multidrug-Resistance in the United States, Lead author: Mera RM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline (TIG) Tested Against Serine Carbapenemase-Producing Enterobacteriaceae Isolated in the United States, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular and Epidemiologic Characterization of Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Isolated from North American Medical Centers: Report from The SENTRY Program (2000- 2004), Lead author: Deshpande LM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular Characterization of S. aureus (SA) Isolates from a Contemporary (2005) Clinical Trial of Uncomplicated Skin and Skin Structure Infections (uSSSI), Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline against Community-Acquired Methicillin-Resistant S. aureus (CA-MRSA) Isolated in North American Medical Centers, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Time to Sign and Symptom (S&S) Resolution May Not Differ Between Bacterially and Non-Bacterially Infected Patients with Acute Maxillary Sinusitis (AMS), Lead author: Ambrose PG, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Potency and Spectrum of Garenoxacin Tested Against an International Collection of Skin and Soft Tissue Infection Pathogens: Report from the SENTRY Antimicrobial Surveillance Program (1999-2004), Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Antimicrobial Activity of Garenoxacin (GRN), a Novel Des-F(6) Quinolone Tested Against 29,460 Community-Acquired Respiratory Pathogens (CA-RTI) from Europe, North America and Latin America, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Uniformly Enhanced Activity of Doripenem Compared to Other Carbapenems (Imipenem, Meropenem) When Testing P. aeruginosa Isolates: Results from Three Continents, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Comparative In Vitro Activity of Ceftobiprole Against Staphylococcus aureus and Streptococcus pneumoniae: Results From an International Surveillance Programme (2003-2005), Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Use of In Vitro Susceptibility and Pathogen Prevalence Data to Model the Expected Clinical Success Rates of Tigecycline and Other Commonly Used Antimicrobials for Empiric Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in France, Germany and Italy, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Surrogate Glycopeptide Testing Used to Predict Susceptibility to Dalbavancin: A Novel Glycolipopeptide, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Antimicrobial Activity of Daptomycin Tested Against Staphylococcus aureus and Enterococcus spp. Clinical Strains Isolated in European Medical Centers (2002-2005), Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Tigecycline Activity Tested Against Gram-positive Cocci and Enterobacteriaceae Collected in Europe, North America and Latin America, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Activity of Meclocycline Sulfosalicylate Tested Against Oral Pathogens, Lead author: Jones RN, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Regional Differences in Activity of Tigecycline Tested Against Acinetobacter spp.: Results from a Global Surveillance Programme (2003-2005), Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Tigecycline Activity Against Staphylococcus aureus, Including Vancomycin-Intermediate and -Resistant Isolates, Lead author: Fritsche TR, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bloodstream Infection Isolates Collected in France, Germany, and Italy, Lead author: Sader HS, presented at 12th annual International Congress on Infectious Diseases (ICID), June 15 – 18, 2006, Lisbon, Portugal

Report from the 2005 Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS), Lead author: Jones RN, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Analysis of the Influence of Surfactant (Tween-80) Concentrations on Susceptibility Testing Results for the Polymyxins by Broth Microdilution Methods, Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Carbapenem -Resistant Serratia marcescens Producing SME-2, a Carbapenem-Hydrolyzing Class A β-Lactamase, Isolated in Houston, Texas: Report from the SENTRY Antimicrobial Surveillance Program (2004), Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Re-Emergence of Linezolid Resistance in Clonally Distinct Staphylococcus aureus Strains Causing Pulmonary Infection in a Cystic Fibrosis Patient: Initial Case Studies from Latin America, Lead author: Deshpande LM, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Report from the 2005 MYSTIC Surveillance Program (USA): Influence of Antimicrobial Resistant Clusters on Overall Prevalence Patterns, Lead author: Rhomberg PR, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

A Multi-Site Study of Gemifloxacin MIC Results on the Sensititre® 18-24 Hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method, Lead author: Miskov AM, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

A Multi-Site Study of Ertapenem MIC Results on the Sensititre® 18-24 hour Automated/Manual Susceptibility Plate to the CLSI Broth Microdilution Method, Lead author: Killian SB, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Multicenter Studies to Establish Tigecycline Disk Diffusion Susceptibility Breakpoints when Testing Acinetobacter spp, Lead author: Jones RN, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Assessment of Colistin and Polymyxin B Antimicrobial Susceptibility Testing Methods Against Non-Fermentative Gram-Negative Bacilli (NFGNB), Lead author: Sader HS, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Disk Diffusion Susceptibility Testing of Campylobacter spp.: Use in Detection of Resistance to Macrolides and Fluoroquinolones, Lead author: Fritsche TR, presented at 106th annual American Society for Microbiology General Meeting (ASM), May 21 – 25, 2006, Orlando, Florida

Antimicrobial Potency and Spectrum of Activity for Meropenem: Report from the USA MYSTIC Programme (2005), Lead author: Rhomberg PR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Efficacy of Tigecycline Tested Against Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Including Analyses of 72 Co-Resistance Patterns, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Activity of Tigecycline Tested Against an International Collection of Minocycline-Resistant Bacterial Pathogens (2000-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Antimicrobial Activity of Tigecycline, a Glycylcycline, Tested Against Carbapenemase-Producing Enterobactereaceae, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Activity of Tigecycline Tested Against an International Collection (2000-2004) of AmpC-Producing Enterobacteriaceae, Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Five Year Evaluation of Clonal Dissemination and Expansion of VIM-1 Producing Enterobacteriaceae in Greece: A Report from the SENTRY Antimicrobial Surveillance Program (2001-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

VIM-1 producing Enterobacter cloacae strains from Madrid, Spain: Report from the SENTRY Antimicrobial Surveillance Program 2005, Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Comparison of Dalbavancin MIC Values Tested Against Gram-Positive Organisms Using Etest (AB BIODISK) and Reference Dilution Methods, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Re-evaluation of the Role of Broad-Spectrum Cephalosporins against Staphylococci Applying Contemporary In Vitro Results and Pharmacokinetic-Pharmacodynamic (PK-PD) Principals, Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Potency of Garenoxacin Tested Against an International Collection of Staphylococcus aureus Isolates, Including Oxacillin- and Ciprofloxacin-Resistant Subsets (2004-2005), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Garenoxacin Activity Tested Against S. pneumoniae, H. influenzae and M. catarrhalis with Elevated or Resistant Fluoroquinolone MIC Values, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Evaluation of Garenoxacin (GRN) Activity Tested Against All Patterns of Multi-Resistant (MDR) S. pneumoniae: Multi-Center Studies of Nearly 15,000 Isolates, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Garenoxacin Activity and Potency against S. pneumoniae and H. influenzae Respiratory Tract Isolates (2004-2005): Report from a Worldwide Surveillance Network, Lead author: Jones RN, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

In Vitro Activity of Garenoxacin Tested Against Ciprofloxacin-Susceptible and -Resistant Enterobacteriaceae and Acinetobacter spp. Strains Collected Worldwide by the SENTRY Antimicrobial Surveillance Program (2004-2005), Lead author: Sader HS, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Contemporary Prevalence of BRO β-Lactamases in M. catarrhalis: Report from the SENTRY Antimicrobial Surveillance Program (USA; 1997-2004), Lead author: Deshpande LM, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Doripenem (DOR) European Surveillance: Antimicrobial Activity Against 6,480 Contemporary Pathogens (2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Analysis of Skin and Soft Tissue Infections in European Medical Centers: Report from the SENTRY Antimicrobial Surveillance Program (1998-2005)., Lead author: Moet G, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Changing Patterns of Antimicrobial Resistances Among Bacterial Isolates Recovered from European Patients Hospitalized with Pneumonia: Report from the SENTRY Antimicrobial Surveillance Programme (1998-2004), Lead author: Fritsche TR, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Cefepime Tested Alone and in Combination with Clavulanic Acid, Gentamicin, and Tobramycin Against Clinical Isolates of Methicillin-Resistant Staphylococcus aureus, Lead author: Rybak M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France

Metallo-Beta-Lactamase Gene bla_SPM-1: Evaluation of its vicinities in unrelated P. aeruginosa strains isolated from distinct Brazilian Hospitals, Lead author: Castanheira M, presented at 16th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 1 – 4, 2006, Nice, France